EMR — Emergent Metals Income Statement
0.000.00%
Last trade - 00:00
- CA$1.93m
- CA$1.90m
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1.67 | 2.64 | 2.69 | 2.34 | 2.32 |
Operating Profit | -1.67 | -2.64 | -2.69 | -2.34 | -2.32 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 0.274 | -2.51 | -0.358 | -0.721 | -1.57 |
Net Income After Taxes | 0.274 | -2.51 | -0.358 | -0.721 | -1.57 |
Net Income Before Extraordinary Items | |||||
Net Income | 0.274 | -2.51 | -0.358 | -0.721 | -1.57 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.274 | -2.51 | -0.358 | -0.721 | -1.57 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.565 | -0.531 | -0.107 | -0.552 | -0.126 |